NS
BMY icon

NewDay Solutions’s Bristol-Myers Squibb BMY Stock Holding History

NewDay Solutions’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$316K Hold
5,376
– – 2.63% 9
2020
Q1 		$341K Sell
5,376
-200
-4% -$12.2K 1.43% 20
2019
Q4 		$358K Buy
5,576
+200
+4% +$11.5K 0.35% 42
2019
Q3 		$279K Hold
5,376
– – 0.2% 47
2019
Q2 		$248K Buy
+5,376
New +$250K 0.18% 50
2018
Q4 		$279K Buy
+5,376
New +$289K 0.26% 46

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

NewDay Solutions's BMY Position: Q2 2020 in Review

NewDay Solutions held its Bristol-Myers Squibb (BMY) position steady in Q2 2020 at 5,376 shares worth $316K. The position accounts for 2.63% of the portfolio, ranked #9.

NewDay Solutions first reported a position in BMY in Q4 2018 and has held it in 6 quarters since. The position peaked at $358K in Q4 2019. 2,189 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • NewDay Solutions held 5,376 shares of Bristol-Myers Squibb worth $316K as of Q2 2020.
  • NewDay Solutions left its Bristol-Myers Squibb share count unchanged in Q2 2020.
  • Bristol-Myers Squibb made up 2.63% of NewDay Solutions's portfolio in Q2 2020, its #9 holding.
  • NewDay Solutions first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 6 quarters since.
  • NewDay Solutions's Bristol-Myers Squibb position peaked at $358K in Q4 2019.
  • 2,189 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on NewDay Solutions's 13F filing for Q2 2020, filed 14 Aug 2020.